ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,018.39
-0.34%
US Tech 100
16,952.00
-0.19%
다우존스 지수
37,903.29
0.23%
Bitcoin
57,601.21
-1.09%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Agios Pharmaceuticals Inc (AGIO)

  7. Agios Pharmaceuticals Inc (AGIO) 뉴스

AGIO Agios Pharmaceuticals Inc

32.60
0.10 (0.31%)
02 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Agios Pharmaceuticals Inc AGIO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.10 0.31% 32.60 06:57:49
개장가 저가 고가 종가 전일 종가
32.30 32.30 34.58 33.66 32.50
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
18/04/202420:00GLOBEAgios to Webcast Conference Call of First Quarter 2024..
09/04/202420:00GLOBEAgios Publishes 2024 Environmental, Social and Governance..
08/03/202408:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202421:00GLOBEAgios to Present at the Leerink Partners Global Biopharma..
02/03/202406:27EDGAR2Form 144 - Report of proposed sale of securities
02/03/202406:26EDGAR2Form 144 - Report of proposed sale of securities
02/03/202406:25EDGAR2Form 144 - Report of proposed sale of securities
02/03/202406:22EDGAR2Form 144 - Report of proposed sale of securities
01/03/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202411:21EDGAR2Form 144 - Report of proposed sale of securities
23/02/202407:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202421:00GLOBEAgios to Present at the TD Cowen 44th Annual Health Care..
16/02/202400:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/02/202421:03EDGAR2Form 8-K - Current report
15/02/202421:00GLOBEAgios Reports Fourth Quarter and Full Year 2023 Financial..
15/02/202407:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202407:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202404:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202404:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/02/202421:00GLOBEAgios to Webcast Conference Call of Fourth Quarter and Year..
25/01/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202406:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202406:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202421:58EDGAR2Form 8-K - Current report
08/01/202421:00GLOBEAgios Announces Key Anticipated 2024 Milestones Across Rare..
06/01/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202420:30GLOBEAgios Announces Phase 3 ENERGIZE Study of Mitapivat Met..
02/01/202421:00GLOBEAgios to Present at the 42nd Annual J.P. Morgan Healthcare..
10/12/202309:00GLOBEAgios Presents Positive Results from Phase 2 Portion of the..
20/11/202321:00GLOBEAgios Announces Clinical Proof-of-Concept in Phase 2a Trial..
02/11/202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202322:05GLOBEAgios Pharmaceuticals to Present Broad Set of Clinical and..
02/11/202320:02EDGAR2Form 8-K - Current report
02/11/202320:00GLOBEAgios Reports Business Highlights and Third Quarter 2023..
29/09/202305:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/08/202320:00GLOBEAgios to Present at the Morgan Stanley Global Healthcare..
22/08/202305:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/08/202305:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
AGIO
Agios Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유